<DOC>
	<DOC>NCT02476422</DOC>
	<brief_summary>The study is designed to assess the efficacy and tolerability of diclofenac potassium soft gelatin capsules compared with ibuprofen tablets in patients with moderate to severe postoperative dental pain.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Key Patients requiring surgical removal of 2 ipsilateral third molars, of which the mandibular must be fully or partially impacted. The ipsilateral maxillary third molar may be of any impaction level. Patients having a moderate to severe Baseline pain intensity as assessed by a score of 2 (moderate) or 3 (severe) on the 4point categorical pain intensity VRS, confirmed by a VASPI score of â‰¥ 50 mm within 5 hours of surgical completion, after local anesthetic dissipation. Key Patients who require the removal of a single third molar, or 2 ipsilateral third molars where mandibular molar is not fully or partially impacted. Patients with active peptic ulcer disease or a history of significant gastrointestinal disease or any gastrointestinal bleeding. Patients with coagulation or bleeding disorders. Patients with a positive drug or alcohol screen. Patients who have received an antiinflammatory agent, analgesic, sedative, hypnotic, muscle relaxant, or tranquilizer within 5 elimination halflives before administration of study drug (other than surgical anesthetic prior to and during dental surgery).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Diclofenac potassium</keyword>
	<keyword>Post-operative dental pain</keyword>
	<keyword>Moderate to severe pain</keyword>
</DOC>